Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum.
D000375:Aging; D000818:Animals; D000918:Antibody Specificity; D001402:B-Lymphocytes / Q000276:immunology*; D002850:Chromatography, Gel; D003602:Cytotoxicity, Immunologic; D004306:Dose-Response Relationship, Immunologic; D005455:Fluorescent Antibody Technique; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D007130:Immunoglobulin Idiotypes; D008223:Lymphoma / Q000628:therapy*; D051379:Mice; D011817:Rabbits
D007130:Immunoglobulin Idiotypes